NDAORALFOR SUSPENSION
Approved
Dec 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
16
Clinical Trials (5)
Cefdinir Capsules 300 mg, Non-fasting
Started Jul 2005
32 enrolled
Healthy
Cefdinir Capsules 300 mg, Fasting
Started Jul 2005
32 enrolled
Healthy
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 300 mg Capsule Fed Conditions
Started Apr 2005
28 enrolled
Healthy
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250mg/5 ml Oral Suspension Fasting Conditions
Started Apr 2005
40 enrolled
Healthy
To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions
Started Apr 2005
40 enrolled
Healthy